The Safety and Effectiveness of Breath-O Lenses

Sponsor
The Hong Kong Polytechnic University (Other)
Overall Status
Completed
CT.gov ID
NCT03616600
Collaborator
SEED Co. Ltd. (Other)
31
1
2
10.5
2.9

Study Details

Study Description

Brief Summary

In Hong Kong, approximately 80% of children are myopic by the end of childhood. There is intense interest currently in the potential role of peripheral defocus as a clinical treatment to slow myopia progression. One of the most successful treatments for myopia is orthokeratology. Currently, Breath-O correct lenses are new designed ready-made orthokeratology lenses. This study is to evaluate the safety of wearing this new orthokeratology lens and the effectiveness of clinical performance in young adult.

Condition or Disease Intervention/Treatment Phase
  • Other: Breath-O-Correct Lens
N/A

Detailed Description

Short-sightedness (myopia) is the most common refractive error in the world. In Hong Kong, approximately 80% of children are myopic by the end of childhood. Current treatment strategies to control (i.e. slow) myopia progression in children are primarily designed to harness the natural "emmetropization" process, in which visual feedback from retinal image clarity regulates the rate of eye growth. There is intense interest currently in the potential role of peripheral defocus as a clinical treatment to slow myopia progression, not least since this approach permits clear central vision. One of the most successful treatments for myopia is orthokeratology, which is a therapy of using custom-made rigid gas permeable contact lens. The special design of this contact lens can reshape the corneal profile to minimize the central refractive error while producing beneficial peripheral defocus. Currently, Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material. This study is to evaluate the safety of wearing this new orthokeratology lens and the effectiveness of clinical performance in young adult.

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized control trialRandomized control trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Safety and Effectiveness of Clinical Performance of Breath-O Correct Orthokeratology Lenses
Actual Study Start Date :
Mar 1, 2018
Actual Primary Completion Date :
Aug 31, 2018
Actual Study Completion Date :
Jan 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment

Wearing the orthokeratology lenses for 3 months

Other: Breath-O-Correct Lens
Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material

No Intervention: Control

Not wearing any contact lenses

Outcome Measures

Primary Outcome Measures

  1. Corneal Biomechanics in Terms of Corneal Hysteresis and Resistance Factor [Baseline, 1st Month, 3rd Month]

    measured by ocular response analyser

  2. Corneal Endothelial Health in Terms of Endothelial Cell Density [Baseline, 1st Month, 3rd Month]

    measured by specular microscope

  3. Corneal Endothelial Health in Terms of Percentage of Variation in Cell Size [Baseline, 1st Month, 3rd Month]

    measured by specular microscope

  4. Anterior Ocular Health in Terms of Limbal and Bulbar Redness [Baseline, 1st Month, 3rd Month]

    measured by OCULUS Keratograph® 5M and graded by JENVIS redness grading system It is a scale of 0 to 4, the higher the score, the more redness the ocular surface manifests

  5. Anterior Ocular Surface Evaluation in Terms of Non-invasive Keratography Break-up Time (NIKBUT) [Baseline, 1st Month, 3rd Month]

    measured by OCULUS Keratograph® 5M

Secondary Outcome Measures

  1. Best Corrected Visual Acuity in Terms of High and Low Contrast [Baseline, 1st Month and the 3rd Month]

    The best corrected visual acuity was measured in LogMAR (Snellen 20/20 vision = 0.00 in LogMAR ; each readable letter add -0.02 to the score, the smaller the number i.e. more negative, the better visual acuity)

  2. Reduction of the Refractive Power After Wearing the Breath-O-correct Lens [Baseline, 1st Week, 1st Month, 3rd Month]

    Refractive errors were determined by subjective refraction for treatment group (Breath-O correct lens wearer), the outcome was represented as mean spherical equivalent refraction with unit in diopter (SER, = 1/2 Cylindrical power + spherical power)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Refractive error: Spherical: normally -1.00D to -4.00D (maximum up to -5.00D); Cylindrical: normally half of Sph (against-the-rule Astigmatism.: lower than -0.75D) (maximum up to -1.50D)

  2. Best corrected Visual acuity: monocular ETDRS 0.0 or better

  3. Ocular health: No ocular abnormality, no contra-indications for overnight orthokeratology lens wear, no refractive surgery

  4. General health: No systemic diseases

  5. Requirement: No history of orthokeratology lens wearing. Agree to participate in this study and willing to wear the orthokeratology lenses overnight in accordance with the instructions given and to come back for follow up within the study period

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Hong Kong Polytechnic University Hong Kong Hong Kong

Sponsors and Collaborators

  • The Hong Kong Polytechnic University
  • SEED Co. Ltd.

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Henry HL Chan, PhD, Assocaite Professor, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT03616600
Other Study ID Numbers:
  • HongKongPU_Optometry2
First Posted:
Aug 6, 2018
Last Update Posted:
Feb 10, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Henry HL Chan, PhD, Assocaite Professor, The Hong Kong Polytechnic University
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Treatment Control
Arm/Group Description Wearing the orthokeratology lenses for 3 months Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Not wearing any contact lenses
Period Title: Overall Study
STARTED 16 15
COMPLETED 15 15
NOT COMPLETED 1 0

Baseline Characteristics

Arm/Group Title Treatment Control Total
Arm/Group Description Wearing the orthokeratology lenses for 3 months Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Not wearing any contact lenses Total of all reporting groups
Overall Participants 15 15 30
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
Between 18 and 65 years
15
100%
15
100%
30
100%
>=65 years
0
0%
0
0%
0
0%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
19.8
(0.7)
22.2
(2.4)
21.1
(2.1)
Sex: Female, Male (Count of Participants)
Female
11
73.3%
9
60%
20
66.7%
Male
4
26.7%
6
40%
10
33.3%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (participants) [Number]
Hong Kong
15
100%
15
100%
30
100%
Refractive errors (Diopters) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Diopters]
-3.47
(1.01)
-3.71
(1.76)
-3.61
(1.40)

Outcome Measures

1. Primary Outcome
Title Corneal Biomechanics in Terms of Corneal Hysteresis and Resistance Factor
Description measured by ocular response analyser
Time Frame Baseline, 1st Month, 3rd Month

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Control
Arm/Group Description Group randomly selected to wear the Breath-O Correct lenses Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Group randomly selected not to wear any contact lenses
Measure Participants 15 15
Corneal Hysteresis_Baseline
11.12
(1.12)
11.10
(1.36)
Corneal Hysteresis_1st Month
10.37
(1.36)
11.20
(1.89)
Corneal Hysteresis_3rd Month
10.14
(0.89)
11.19
(1.66)
Corneal Resistance Factor_Baseline
11.07
(1.32)
11.14
(2.23)
Corneal Resistance Factor_1st Month
9.87
(1.45)
10.92
(2.45)
Corneal Resistance Factor_3rd Month
9.99
(1.37)
10.79
(2.17)
2. Primary Outcome
Title Corneal Endothelial Health in Terms of Endothelial Cell Density
Description measured by specular microscope
Time Frame Baseline, 1st Month, 3rd Month

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Control
Arm/Group Description Group randomly selected to wear the Breath-O Correct lenses Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Group randomly selected not to wear any contact lenses
Measure Participants 15 15
Corneal Endothelial Cell Density_Baseline
2909
(145.1)
2861
(181.05)
Corneal Endothelial Cell Density_1st month
2923
(123.01)
2818
(182.65)
Corneal Endothelial Cell Density_3rd month
2917
(157.34)
2825
(177.80)
3. Secondary Outcome
Title Best Corrected Visual Acuity in Terms of High and Low Contrast
Description The best corrected visual acuity was measured in LogMAR (Snellen 20/20 vision = 0.00 in LogMAR ; each readable letter add -0.02 to the score, the smaller the number i.e. more negative, the better visual acuity)
Time Frame Baseline, 1st Month and the 3rd Month

Outcome Measure Data

Analysis Population Description
It is a comparison of visual performance before-and-after treatment and therefore only the best corrected visual acuity in treatment group in different time points were compared.
Arm/Group Title Treatment
Arm/Group Description Group randomly selected to wear the Breath-O Correct lenses
Measure Participants 15
High contrast VA_Baseline
-0.10
(0.06)
High contrast VA_1st Month
-0.07
(0.08)
High contrast VA_3rd Month
-0.08
(0.08)
Low contrast VA_Basline
0.08
(0.08)
Low contrast VA_1st Month
0.22
(0.14)
Low contrast VA_3rd Month
0.17
(0.13)
4. Secondary Outcome
Title Reduction of the Refractive Power After Wearing the Breath-O-correct Lens
Description Refractive errors were determined by subjective refraction for treatment group (Breath-O correct lens wearer), the outcome was represented as mean spherical equivalent refraction with unit in diopter (SER, = 1/2 Cylindrical power + spherical power)
Time Frame Baseline, 1st Week, 1st Month, 3rd Month

Outcome Measure Data

Analysis Population Description
It is a comparison of refractive errors before-and-after treatment and therefore only the refractive errors in treatment group in different time points were compared.
Arm/Group Title Treatment
Arm/Group Description Group randomly selected to wear the Breath-O Correct lenses Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material
Measure Participants 15
Refractive errors_Baseline
-3.52
(1.02)
Refractive errors_1st Week
-0.17
(0.99)
Refractive errors_1st Month
-0.11
(0.92)
Refractive errors_3rd Month
-0.03
(0.82)
5. Primary Outcome
Title Corneal Endothelial Health in Terms of Percentage of Variation in Cell Size
Description measured by specular microscope
Time Frame Baseline, 1st Month, 3rd Month

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Control
Arm/Group Description Group randomly selected to wear the Breath-O Correct lenses Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Group randomly selected not to wear any contact lenses
Measure Participants 15 15
Corneal Endothelial Cell Variance_Baseline
28.68
(3.78)
29.35
(3.66)
Corneal Endothelial Cell Variance_1st month
28.47
(3.51)
29.00
(3.58)
Corneal Endothelial Cell Variance_3rd month
29.00
(6.53)
30.01
(3.32)
6. Primary Outcome
Title Anterior Ocular Health in Terms of Limbal and Bulbar Redness
Description measured by OCULUS Keratograph® 5M and graded by JENVIS redness grading system It is a scale of 0 to 4, the higher the score, the more redness the ocular surface manifests
Time Frame Baseline, 1st Month, 3rd Month

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Control
Arm/Group Description Group randomly selected to wear the Breath-O Correct lenses Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Group randomly selected not to wear any contact lenses
Measure Participants 15 15
Bulbar redness_Baseline
0.57
(0.18)
0.58
(0.28)
Bulbar redness_1st Month
0.47
(0.19)
0.52
(0.21)
Bulbar redness_3rd Month
0.54
(0.31)
0.61
(0.27)
Limbal redness_Baseline
0.26
(0.19)
0.29
(0.26)
Limbal redness_1st Month
0.23
(0.15)
0.31
(0.21)
Limbal redness_3rd Month
0.27
(0.21)
0.38
(0.28)
7. Primary Outcome
Title Anterior Ocular Surface Evaluation in Terms of Non-invasive Keratography Break-up Time (NIKBUT)
Description measured by OCULUS Keratograph® 5M
Time Frame Baseline, 1st Month, 3rd Month

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment Control
Arm/Group Description Group randomly selected to wear the Breath-O Correct lenses Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Group randomly selected not to wear any contact lenses
Measure Participants 15 15
NIKBUT_1st break_Baseline
6.72
(3.96)
9.92
(6.76)
NIKBUT_1st break_1st Month
9.13
(5.45)
9.17
(5.63)
NIKBUT_1st break_3rd Month
9.83
(6.37)
7.64
(4.97)
NIKBUT_average_Baseline
10.94
(4.15)
13.24
(6.56)
NIKBUT_average_1st Month
12.42
(5.73)
11.86
(5.99)
NIKBUT_average_3rd Month
12.07
(6.76)
9.57
(5.02)

Adverse Events

Time Frame 3 months
Adverse Event Reporting Description
Arm/Group Title Treatment Control
Arm/Group Description Wearing the orthokeratology lenses for 3 months Breath-O-Correct Lens: Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material Not wearing any contact lenses
All Cause Mortality
Treatment Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/16 (0%) 0/15 (0%)
Serious Adverse Events
Treatment Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/16 (0%) 0/15 (0%)
Other (Not Including Serious) Adverse Events
Treatment Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 1/16 (6.3%) 0/15 (0%)
Eye disorders
poor visual quality 1/16 (6.3%) 0/15 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Henry Chan
Organization Hong Kong Polytechnic University
Phone +85227667937
Email henryhl.chan@polyu.edu.hk
Responsible Party:
Henry HL Chan, PhD, Assocaite Professor, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT03616600
Other Study ID Numbers:
  • HongKongPU_Optometry2
First Posted:
Aug 6, 2018
Last Update Posted:
Feb 10, 2021
Last Verified:
Jan 1, 2021